Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Epilepsy

  Free Subscription


Articles published in J Neuropathol Exp Neurol

Retrieve available abstracts of 6 articles:
HTML format



Single Articles


    December 2020
  1. VASUDEVARAJA V, Rodriguez JH, Pelorosso C, Zhu K, et al
    Somatic Focal Copy Number Gains of Noncoding Regions of Receptor Tyrosine Kinase Genes in Treatment-Resistant Epilepsy.
    J Neuropathol Exp Neurol. 2020 Dec 4. pii: 6020100. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  2. CHEN X, Liu K, Lin Z, Huang K, et al
    Knockout of Transient Receptor Potential Melastatin 4 Channel Mitigates Cerebral Edema and Neuronal Injury After Status Epilepticus in Mice.
    J Neuropathol Exp Neurol. 2020 Nov 13. pii: 5981530. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  3. STEFANITS H, Milenkovic I, Mahr N, Pataraia E, et al
    Alterations in GABAA Receptor Subunit Expression in the Amygdala and Entorhinal Cortex in Human Temporal Lobe Epilepsy.
    J Neuropathol Exp Neurol. 2019;78:1022-1048.
    PubMed     Abstract available


    September 2019
  4. SARNAT HB
    Proteoglycan (Keratan Sulfate) Barrier in Developing Human Forebrain Isolates Cortical Epileptic Networks From Deep Heterotopia, Insulates Axonal Fascicles, and Explains Why Axosomatic Synapses Are Inhibitory.
    J Neuropathol Exp Neurol. 2019 Sep 21. pii: 5601672. doi: 10.1093.
    PubMed     Abstract available


    October 2017
  5. AL-HAJRI A, Al-Mughairi S, Somani A, An S, et al
    Pathology-MRI Correlations in Diffuse Low-Grade Epilepsy Associated Tumors.
    J Neuropathol Exp Neurol. 2017 Oct 12. doi: 10.1093.
    PubMed     Abstract available


    March 2017
  6. LU JQ, Steve TA, Wheatley M, Gross DW, et al
    Immune Cell Infiltrates in Hippocampal Sclerosis: Correlation With Neuronal Loss.
    J Neuropathol Exp Neurol. 2017;76:206-215.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: